New study aims to ease life after ovarian and endometrial cancer

NCT ID NCT05731661

First seen Dec 26, 2025 · Last updated Jun 22, 2026 · Updated 32 times

Summary

This study tests a personalized post-cancer care plan for women who have finished treatment for ovarian or endometrial cancer. About 99 participants will receive a day of support care and a tailored plan to address their needs. The goal is to see if this approach improves their long-term quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre Francois Baclesse

    Caen, 14076, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

personalized post-cancer care plan

What this could lead to

If successful, this could lead to better long-term support and quality of life for women after pelvic cancer treatment.

What could go wrong

This is a small pilot study with no control group, so results may not be generalizable. It focuses on care coordination, not a new treatment.

Conditions

The condition(s) this trial relates to.

endometrial cancer fallopian tube cancer female reproductive organ cancer ovarian cancer peritoneum cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.